Recently, using whole genome sequencing datasets generated in our laboratory and by TCGA, we identified a population of GBM tumors that exhibited MDM4 amplifications that appeared to be mutually exclusive with the MDM2 amplification that was previously reported. The gene discussed is MDM2; the disease is glioblastoma.